StocksE › EGAN

eGain Corporation (EGAN) — Earnings Call X-Ray

Our AI read all 38 of EGAN's earnings calls (2016–2025) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.

Latest Call Grade
🔒
Q3 2025 · sign up to see
Previous Call Grade
C
Q2 2025
Expected Move
🔒
next 45 days · members
Calls Analyzed
38
2016–2025
Avg Candor
6.8/9
evasion 2.1/9
Guidance LoweredHigh CandorCritic AmmunitionFounder-LedEarly Product, Fast GrowthMargins ContractingDemand AcceleratingHidden Segment

Call-by-call analysis

🔒 Q3 2025 earnings call 2025-05-14 NEWEST

Guidance: ■■■■■Demand: ■■■■■■ Margins: ■■■■Backlog: ■■■■ ■ analysts, ■■ questionsexpected move ±■■%
Candor /9
Specificity /9
Evasion /9
Stress /9

Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.

🔒 The Q3 2025 call grade is ready
The full 37-point AI read of EGAN's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock

C Q2 2025 earnings call 2025-02-13 move ±23.4%

Management lowered guidance against accelerating demand and contracting margins. The delivery was unusually candid, rich in specifics.

Guidance: loweredDemand: acceleratingMargins: contractingBacklog: stablePricing: stable 1 analysts · 2 questions
⚑ Critic ammunition✓ Resolves doubts✓ Early product, fast growth⚑ Reads rehearsedFounder-ledHidden segment
Candor 7/9
Specificity 8/9
Evasion 1/9
Confidence 7/9
Uncertainty 5/9
Promotion 6/9
Stress 3/9
Complexity 4/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
YES Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

C Q1 2025 earnings call 2024-11-15 move ±15.6%

Management held guidance steady against accelerating demand and contracting margins.

Guidance: maintainedDemand: acceleratingMargins: contractingBacklog: shrinkingPricing: stableCapex: increasing 2 analysts · 7 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritable✓ Resolves doubts✓ Early product, fast growth⚑ Reads rehearsed
Candor 6/9
Specificity 6/9
Evasion 3/9
Confidence 7/9
Uncertainty 3/9
Promotion 6/9
Stress 2/9
Complexity 4/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

C Q4 2024 earnings call 2024-09-05 move ±21%

Management lowered guidance against accelerating demand and contracting margins. The delivery was unusually candid, rich in specifics.

Guidance: loweredDemand: acceleratingMargins: contractingBacklog: shrinkingPricing: stableCapex: increasing 2 analysts · 8 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritable✓ Resolves doubts✓ Early product, fast growthFounder-led
Candor 7/9
Specificity 8/9
Evasion 2/9
Confidence 8/9
Uncertainty 3/9
Promotion 6/9
Stress 2/9
Complexity 4/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

D Q3 2024 earnings call 2024-05-12 move ±14%

Management lowered guidance against accelerating demand and expanding margins. The delivery was unusually candid, rich in specifics.

Guidance: loweredDemand: acceleratingMargins: expandingBacklog: shrinkingPricing: stable 2 analysts · 5 questions
⚑ Critic ammunition⚑ Question left hanging✓ Early product, fast growth⚑ Reads rehearsedFounder-ledHidden segment
Candor 7/9
Specificity 8/9
Evasion 2/9
Confidence 8/9
Uncertainty 3/9
Promotion 6/9
Stress 2/9
Complexity 4/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

D Q2 2024 earnings call 2024-02-08 move ±28.6%

Management lowered guidance against mixed demand signals and expanding margins. The delivery was unusually candid, rich in specifics.

Guidance: loweredDemand: mixedMargins: expandingBacklog: shrinkingPricing: stable 2 analysts · 8 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritable✓ Early product, fast growthHidden segmentDirection beats results
Candor 8/9
Specificity 7/9
Evasion 2/9
Confidence 6/9
Uncertainty 4/9
Promotion 6/9
Stress 4/9
Complexity 4/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

B+ Q1 2024 earnings call 2023-11-03 move ±9.5%

Management raised guidance against mixed demand signals and expanding margins. The delivery was unusually candid, rich in specifics.

Guidance: raisedDemand: mixedMargins: expandingBacklog: shrinkingPricing: stable 2 analysts · 5 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts⚑ Reads rehearsedFounder-led
Candor 7/9
Specificity 8/9
Evasion 2/9
Confidence 7/9
Uncertainty 4/9
Promotion 6/9
Stress 2/9
Complexity 3/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
YES Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

C+ Q4 2023 earnings call 2023-09-14 move ±15.8%

Management held guidance steady against accelerating demand and expanding margins. The delivery was unusually candid, rich in specifics.

Guidance: maintainedDemand: acceleratingMargins: expandingBacklog: growingPricing: stableHeadcount: flat 2 analysts · 8 questions
⚑ Critic ammunition✓ Skeptic reassured⚑ Question left hanging✓ Resolves doubts✓ Prepayments growingFounder-led
Candor 7/9
Specificity 7/9
Evasion 2/9
Confidence 6/9
Uncertainty 5/9
Promotion 4/9
Stress 3/9
Complexity 3/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
YES Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
YES Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

Earlier calls

CallDateGradeGuidanceDemandMarginsCandorEvasion
Q3 2023 2023-05-11 D loweredmixedcontracting 7/9 2/9
Q2 2023 2023-02-14 D loweredslowingcontracting 7/9 3/9
Q1 2023 2022-11-15 D loweredmixedcontracting 7/9 2/9
Q4 2022 2022-09-08 C+ maintainedmixedcontracting 6/9 3/9
Q3 2022 2022-05-07 A raisedacceleratingstable 6/9 2/9
Q2 2022 2022-02-03 A raisedacceleratingexpanding 6/9 2/9
Q1 2022 2021-11-09 B+ raisedacceleratingcontracting 7/9 1/9
Q4 2021 2021-09-01 B+ raisedacceleratingexpanding 6/9 2/9
Q3 2021 2021-05-11 B maintainedacceleratingexpanding 7/9 2/9
Q2 2021 2021-02-10 B maintainedacceleratingexpanding 7/9 2/9
Q1 2021 2020-11-10 C loweredmixedexpanding 8/9 2/9
Q4 2020 2020-09-02 B maintainedstableexpanding 7/9 2/9
Q3 2020 2020-05-08 B+ raisedmixedstable 7/9 2/9
Q2 2020 2020-02-06 B+ raisedmixedexpanding 7/9 2/9
Q1 2020 2019-11-08 B maintainedacceleratingexpanding 7/9 2/9
Q4 2019 2019-09-03 B+ raisedacceleratingcontracting 7/9 2/9
Q3 2019 2019-05-08 B+ raisedacceleratingexpanding 7/9 2/9
Q2 2019 2019-02-07 A raisedacceleratingexpanding 6/9 2/9
Q1 2019 2018-11-11 B+ maintainedacceleratingexpanding 6/9 2/9
Q4 2018 2018-09-06 C+ maintainedacceleratingstable 6/9 2/9
Q3 2018 2018-05-07 A raisedacceleratingexpanding 7/9 2/9
Q2 2018 2018-02-08 B+ maintainedstableexpanding 7/9 2/9
Q1 2018 2017-11-08 C+ maintainedacceleratingexpanding 6/9 2/9
Q4 2017 2017-09-06 B maintainedstableexpanding 7/9 1/9
Q3 2017 2017-05-10 B noneacceleratingcontracting 7/9 1/9
Feb 2017 2017-02-09 D nonemixedexpanding 7/9 3/9
Q1 2017 2016-11-09 C+ noneacceleratingexpanding 7/9 3/9
Q4 2016 2016-09-08 C+ maintainedacceleratingexpanding 7/9 3/9
Q3 2016 2016-05-07 D loweredmixedexpanding 7/9 2/9
Q2 2016 2016-02-04 D maintainedmixedexpanding 6/9 5/9

Research question bank — earlier calls

During our 1,600-question research program, batches of experimental hypotheses were tested directly against some of EGAN's earlier calls. The YES answers — the rare hits — are shown; click any question to see every company that matched it. Full list: the question bank.

D Q3 2023 earnings call 2023-05-11

1 more research questions answered NO

D Q2 2023 earnings call 2023-02-14

How to read this page

The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.

Companies with similar call quality

AAP · Advance Auto Parts, Inc.ABCAF · Athabasca Minerals, Inc.ABDC · Alcentra Capital'sABMD · Abiomed, Inc.ABNRY · ABN AMRO Bank N.V.ABOS · Acumen Pharmaceuticals,

EG   All “E” companies    EGAS

Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.